Eos Focused Equity Management adds Danaher Corporation (DHR) to its portfolio

Danaher Corporation (DHR) : Eos Focused Equity Management added new position in Danaher Corporation during the most recent quarter end. The investment management firm now holds 40,432 shares of Danaher Corporation which is valued at $3,296,825 , the company said in a statement filed on Aug 9, 2016 with the SEC.Danaher Corporation makes up approximately 3.34% of Eos Focused Equity Management’s portfolio.

Other Hedge Funds, Including , First Long Island Investors sold out all of its stake in DHR during the most recent quarter. The investment firm sold 3,000 shares of DHR which is valued $243,840.Tirschwell Loewy Inc reduced its stake in DHR by selling 4,300 shares or 1.71% in the most recent quarter. The Hedge Fund company now holds 246,596 shares of DHR which is valued at $20,097,574. Danaher Corporation makes up approx 3.32% of Tirschwell Loewy Inc’s portfolio.Chase Investment Counsel Corp reduced its stake in DHR by selling 1,245 shares or 2.01% in the most recent quarter. The Hedge Fund company now holds 60,837 shares of DHR which is valued at $4,918,671. Danaher Corporation makes up approx 2.10% of Chase Investment Counsel Corp’s portfolio.Canandaigua National Bank Trust Co reduced its stake in DHR by selling 90 shares or 0.48% in the most recent quarter. The Hedge Fund company now holds 18,545 shares of DHR which is valued at $1,499,363. Danaher Corporation makes up approx 0.43% of Canandaigua National Bank Trust Co’s portfolio.

Danaher Corporation opened for trading at $80.82 and hit $81.05 on the upside on Wednesday, eventually ending the session at $81.02, with a gain of 0.40% or 0.32 points. The heightened volatility saw the trading volume jump to 16,06,048 shares. Company has a market cap of $55,947 M.

On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.

Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.

Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.

Leave a Reply

Danaher Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Danaher Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.